Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
4,407 Dovepress* 3,381 569+ 917 3,950
PubMed Central* 0 457 126 457
Totals 3,381 1,026 1,043 4,407
*Since 18 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar